【HWGB 9601 交流专区】豪华云顶

icy97

HO WAH GENTING BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Others
Details of corporate proposal	SETTLEMENT OF DEBT OWING TO CREDITORS OF HO WAH GENTING BERHAD ("HWGB") TO BE SATISFIED ENTIRELY VIA THE ISSUANCE OF NEW ORDINARY SHARES IN HWGB ("CREDITORS CAPITALISATION")
No. of shares issued under this corporate proposal	102,666,900
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0804
Par Value($$) (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units	459,738,740
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 97,525,332.000
Listing Date	01 Nov 2019

icy97

Notice of Interest Sub. S-hldr (Section 137 of CA 2016)

HO WAH GENTING BERHAD

Particulars of Substantial Securities Holder

Name	VITAXEL HOTELS GROUP SDN. BHD.
Address	Wisma Ho Wah Genting No. 35, Jalan Maharajalela Kuala Lumpur 50150 Wilayah Persekutuan Malaysia.
Company No.	1088957-D
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares
Name & address of registered holder	Vitaxel Hotels Group Sdn BhdWisma Ho Wah GentingNo. 35, Jalan Maharajalela50150 Kuala Lumpur

Date interest acquired & no of securities acquired
Date interest acquired	30 Oct 2019
No of securities	51,292,500
Circumstances by reason of which Securities Holder has interest	Settlement of shares pursuant to Debt Settlement Agreement
Nature of interest	Direct Interest
Total no of securities after change
Direct (units)	51,292,500
Direct (%)	11.16
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Date of notice	01 Nov 2019
Date notice received by Listed Issuer	01 Nov 2019

icy97

Notice of Interest Sub. S-hldr (Section 137 of CA 2016)

HO WAH GENTING BERHAD

Particulars of Substantial Securities Holder

Name	FINANCIAL FRONTIERS PTE. LTD.
Address	7030 Ang Mo Kio Avenue 5 #09-90, Northstar @ AMK 569880 Singapore.
Company No.	200204195N
Nationality/Country of incorporation	Singapore
Descriptions (Class)	Ordinary Shares
Name & address of registered holder	Financial Frontiers Pte. Ltd.7030 Ang Mo Kio Avenue 5,#09-90, Northstar @ AMK, 569880 Singapore

Date interest acquired & no of securities acquired
Date interest acquired	30 Oct 2019
No of securities	51,374,400
Circumstances by reason of which Securities Holder has interest	Settlement shares pursuant to Debt Settlement Agreement
Nature of interest	Direct Interest
Total no of securities after change
Direct (units)	51,374,400
Direct (%)	11.17
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Date of notice	01 Nov 2019
Date notice received by Listed Issuer	01 Nov 2019

icy97

Changes in Sub. S-hldr's Int (Section 138 of CA 2016)

HO WAH GENTING BERHAD

Particulars of substantial Securities Holder

Name	VITAXEL HOTELS GROUP SDN. BHD.
Address	Wisma Ho Wah Genting No. 35, Jalan Maharajalela Kuala Lumpur 50150 Wilayah Persekutuan Malaysia.
Company No.	1088957-D
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	04 Nov 2019	10,000,000	Disposed	Direct Interest
	Name of registered holder	VITAXEL HOTELS GROUP SDN. BHD.
	Address of registered holder	Wisma Ho Wah Genting No. 35, Jalan Maharajalela 50150 Kuala Lumpur
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Disposal of shares
Nature of interest	Direct Interest
Direct (units)	41,292,500
Direct (%)	8.98
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	41,292,500
Date of notice	05 Nov 2019
Date notice received by Listed Issuer	05 Nov 2019

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2019

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2019	30 Sep 2018	30 Sep 2019	30 Sep 2018
		$$'000	$$'000	$$'000	$$'000

1	Revenue	47,222	44,102	146,592	121,259
2	Profit/(loss) before tax	-379	121	-251	-2,188
3	Profit/(loss) for the period	-722	-2,178	-1,906	-4,688
4	Profit/(loss) attributable to ordinary equity holders of the parent	-722	-2,106	-1,906	-4,327
5	Basic earnings/(loss) per share (Subunit)	-0.21	-0.70	-0.55	-1.44
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0900		0.0900

icy97

Notice of Person Ceasing (Section 139 of CA 2016)

HO WAH GENTING BERHAD

Particulars of Substantial Securities Holder

Name	VITAXEL HOTELS GROUP SDN. BHD.
Address	Wisma Ho Wah Genting No. 35, Jalan Maharajalela Kuala Lumpur 50150 Wilayah Persekutuan Malaysia.
Company No.	1088957-D
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares
Date of cessation	05 Dec 2019
Name & address of registered holder	Vitaxel Hotels Group Sdn BhdWisma Ho Wah GentingNo. 35, Jalan Maharajalela50150 Kuala Lumpur

No of securities disposed	12,500,000
Circumstances by reason of which a person ceases to be a substantial shareholder	Disposal in open market
Nature of interest	Direct Interest
Date of notice	09 Dec 2019
Date notice received by Listed Issuer	09 Dec 2019

icy97

HO WAH GENTING BERHAD

Particulars of substantial Securities Holder

Name	FINANCIAL FRONTIERS PTE. LTD.
Address	7030 Ang Mo Kio Avenue 5 #09-90, Northstar @ AMK 569880 Singapore.
Company No.	200204195N
Nationality/Country of incorporation	Singapore
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	19 Dec 2019	18,389,600	Disposed	Direct Interest
	Name of registered holder	FINANCIAL FRONTIERS PTE. LTD.
	Address of registered holder	7030 Ang Mo Kio Avenue 5, #09-90, Northstar @ AMK, 569880 Singapore
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Disposal of shares
Nature of interest	Direct Interest
Direct (units)	32,984,800
Direct (%)	7.175
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	32,984,800
Date of notice	20 Dec 2019
Date notice received by Listed Issuer	20 Dec 2019

icy97

Notice of Person Ceasing (Section 139 of CA 2016)

HO WAH GENTING BERHAD

Particulars of Substantial Securities Holder

Name	FINANCIAL FRONTIERS PTE. LTD.
Address	7030 Ang Mo Kio Avenue 5 #09-90, Northstar @ AMK 569880 Singapore.
Company No.	200204195N
Nationality/Country of incorporation	Singapore
Descriptions (Class)	Ordinary Shares
Date of cessation	30 Dec 2019
Name & address of registered holder	Financial Frontiers Pte. Ltd.7030 Ang Mo Kio Avenue 5,#09-90, Northstar @ AMK, 569880 Singapore

No of securities disposed	14,595,200
Circumstances by reason of which a person ceases to be a substantial shareholder	Disposal of shares
Nature of interest	Direct Interest
Date of notice	02 Jan 2020
Date notice received by Listed Issuer	02 Jan 2020

icy97

Type	Announcement
Subject	OTHERS
Description	HO WAH GENTING BERHAD - Incorporation of new subsidiary
The Board of Directors wishes to announce that Ho Wah Genting Berhad has incorporated a subsidiary namely,  3H HEALTHTECH AI SDN BHD. on 17 February 2020. Kindly refer to the attached file for details of the announcement. This announcement is dated 18 February 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3024345

Attachments Incorporation New Subsi- 3H HEALTHTECH AI SDN BHD.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	Appointment of Guardion Health Sciences, Inc.
The Board of Directors wishes to announce that Ho Wah Genting Berhad (“HWGB” or the Company”) had appointed Guardion Health Sciences, Inc., with its principal place of business located at 15150 Avenue of Science, Suite 200, San Diego, California 92128, a company listed on Nasdaq (“GHSI”) of United States of America to design and manufacture an exclusive custom immune support nutraceutical formula. The formulation will be for exclusive use and will be owned by HWGB and must be produced under the brand name to be determined. Please refer to attachment for the letter of appointment dated 21 February 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3027319

Attachments Guardion-Letter of appointment.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2019

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2019	31 Dec 2018	31 Dec 2019	31 Dec 2018
		$$'000	$$'000	$$'000	$$'000

1	Revenue	34,378	38,448	180,970	159,707
2	Profit/(loss) before tax	-5,572	1,413	-5,823	-775
3	Profit/(loss) for the period	-5,084	-1,693	-6,990	-6,381
4	Profit/(loss) attributable to ordinary equity holders of the parent	-5,084	-28,665	-6,990	-32,992
5	Basic earnings/(loss) per share (Subunit)	-1.38	-9.37	-1.90	-10.79
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0700		0.0900

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	HO WAH GENTING BERHAD ("HWGB" OR THE "COMPANY") PROPOSED PRIVATE PLACEMENT OF UP TO 10% OF THE ISSUED SHARES IN HWGB
On behalf of the Board of Directors of HWGB, M&A Securities Sdn Bhd wishes to announce that the Company proposes to implement a private placement of up to 10% of the issued share capital of HWGB, involve the issuance of up to 47,732,276 new ordinary shares in HWGB (“Proposed Private Placement”). Further information on the Proposed Private Placement is disclosed in the attachment herein. This announcement is dated 11 March 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3033145

Attachments HWGB - PP.pdf

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	HO WAH GENTING BERHAD ("HWGB" OR THE "COMPANY") PROPOSED PRIVATE PLACEMENT OF UP TO 10% OF THE ISSUED SHARES IN HWGB
Unless otherwise defined, the definitions set out in the announcement dated 11 March 2020 (“Announcement”) shall apply herein. Further to the Announcement in relation to the Proposed Private Placement, M&A Securities on behalf of the Board wishes to announce additional information in relation to the Proposed Private Placement as set out in the attachement below. This announcement is dated 25 March 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3039055

Attachments Additional announcement - Final.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	HO WAH GENTING BERHAD - Incorporation of New subsidiary
The Board of Directors wishes to announce that Ho Wah Genting Berhad has incorporated a subsidiary namely,  ASTRAMUNE SDN BHD on 13 March 2020. Kindly refer to the attached file for details of the announcement. This announcement is dated 16 March 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3034966

Attachments Incorp Subsi-ASTRAMUNE-13.03.2020.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	AUTHORIZATION AS SALES AGENT OF XIAMEN AMONMED BIOTECHNOLOGY CO. LTD. FOR COVID-19 DIAGNOSTIC PROCDUCTS
The Board of Directors wishes to announce that Ho Wah Genting Berhad (“HWGB” or the Company”) has received a certificate of authorisation dated 17 March 2020 from Xiamen AmonMed Biotechnology Co. Ltd, with its principal place of business located Unit 503, No. 120, Xinyuan Road, Haicang District, Xiamen, China, for the appointment of HWGB as its designated abroad sales agent for COVID-19 diagnostic products in the region of Malaysia, Singapore, Indonesia and Thailand (“Appointment”).  The validity of the authorisation is from 17 March 2020 to 16 March 2021. Subsequently, the Company had also on the same day submitted an application to the Ministry of Health, Malaysia for the certification of the COVID-19 diagnostic products. Further details will be announced upon the finalisation of the terms and conditions of the Appointment. This announcement is dated 18 March 2020.

malay86

豪华云顶刚刚宣布获得上海良润在马来西亚的经销权，可在马来西亚分销冠状病毒病诊断试剂盒。
https://500shares.com.my/?p=1396

icy97

Type	Announcement
Subject	OTHERS
Description	HO WAH GENTING BERHAD ("HWGB" OR "COMPANY")PROPOSED DIVERSIFICATION OF THE EXISTING BUSINESSES OF HWGB AND ITS SUBSIDIARIES ("HWGB GROUP" OR "GROUP") TO INCLUDE THE HEALTHCARE RELATED BUSINESS ("PROPOSED DIVERSIFICATION")
On behalf of the board of directors of HWGB, M&A Securities Sdn Bhd wishes to announce that the Company proposes to undertake the Proposed Diversification. Please refer to the attachment for further details on the Proposed Diversification. This announcement is dated 25 March 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3038901

Attachments Final - Proposed Diversification.pdf

icy97

icy97 发表于 27-4-2020 07:49 AM
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3027319

HO WAH GENTING BERHAD

Type	Announcement
Subject	OTHERS
Description	Appointment of Guardion Health Sciences, Inc.
Reference is made to the announcement dated 21 February 2020 in relation to the appointment of Guardion Health Sciences, Inc (“GHSI”) to design and manufacture an exclusive custom immune support nutraceutical formula  for exclusive use and will be owned by Ho Wah Genting Berhad (“HWGB”) and must be produced under the brand name to be determined (“Appointment”). Following the Appointment, the Board of Directors of HWGB is pleased to announce that HWGB and Astramune Sdn Bhd (“ASB”) (a wholly-owned subsidiary of HWGB) had on 30 March 2020 (“Effective Date”) entered into a manufacturing and supply agreement with GHSI (“Manufacturing and Supply Agreement”) to set out the detailed terms and conditions of the Appointment. Please refer to attach file for the details of the announcement.  This announcement is dated 31 March 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3040569

Attachments Manufacturing and Supply Agreement with GHSI-31.03.2020.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	AUTHORISATION AS DISTRIBUTOR OF WUHAN EASYDIAGNOSIS BIOMEDICINE CO. LTD. FOR COVID-19 NUCLEIC ACID TEST KIT AND NUCLEIC ACID EXTRACTION REAGENT
The Board of Directors wishes to announce that Ho Wah Genting Berhad (“HWGB” or the Company”) had on 3 April 2020 received a letter of authorisation dated 20 March 2020 from Wuhan Easydiagnosis Biomedicine Co. Ltd.(“WEBC”), for the authorisation of HWG Consortium Sdn Bhd (a wholly owned subsidiary of HWGB) as the distributor of its COVID-19 Nucleic Acid Test Kit and Nucleic Acid Extraction Reagent in Malaysia (“Products”) (“Authorisation”). The validity of the Authorisation is from 20 March 2020 to 20 March 2021. Subsequently, the Company had also on 3 April 2020 submitted an application to the Ministry of Health, Malaysia for the certification of the Products. Information on WEBC WEBC (listed on Shenzhen Stock Exchange, Stock Code: 002932), with its principal place of business at Room 3, Factory (3), 1st Floor, Building 25, Phase 3.1 Wuhan Optics Valley International Biopharmaceutical Enterprise Accelerator, No. 388, Gaoxin 2nd Road, East Lake Hi-Tech Development Zone, 430074, Wuhan, Hubei, China is an In Vitro Diagnostics manufacturer, specialising in development, production and sales of point-of-care testing rapid diagnostic reagents and related equipment. WEBC is authorised to export medical products by Ministry of Commerce of the People's Republic of China. This announcement is dated 3 April 2020.

icy97

HO WAH GENTING BERHAD

Particulars of substantial Securities Holder

Name	HO WAH GENTING HOLDING SDN BHD
Address	Wisma Ho Wah Genting 1st Floor, No. 35, Jalan Maharajalela Kuala Lumpur 50150 Wilayah Persekutuan Malaysia.
Company No.	199901001095/475995-U
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	03 Apr 2020	12,500,000	Acquired	Direct Interest
	Name of registered holder	Ho Wah Genting Holding Sdn Bhd
	Address of registered holder	Wisma Ho Wah Genting 1st Floor, No. 35, Jalan Maharajalela 50150 Kuala Lumpur
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Direct Deal
Nature of interest	Direct Interest
Direct (units)	109,955,200
Direct (%)	23.92
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	109,955,200
Date of notice	06 Apr 2020
Date notice received by Listed Issuer	06 Apr 2020

icy97

HO WAH GENTING BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Private Placement
Details of corporate proposal	HO WAH GENTING BERHAD ("HWGB" OR THE "COMPANY") PRIVATE PLACEMENT OF UP TO 10% OF THE ISSUED SHARES IN HWGB
No. of shares issued under this corporate proposal	45,973,800
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0920
Par Value($$) (if applicable)	Malaysian Ringgit (MYR)   0.000
Latest issued share capital after the above corporate proposal in the following
Units	505,712,540
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 101,754,921.210
Listing Date	08 Apr 2020